Publications COVID-19 Wael Rabeh 8/20/24 COVID-19 Wael Rabeh 8/20/24 The Discovery of Novel Small Oxindole-Based Inhibitors Targeting the SARS-CoV-2 Main Protease (Mpro) Read More COVID-19 Wael Rabeh 8/20/24 COVID-19 Wael Rabeh 8/20/24 SARS-CoV-2 variants, its recombinants and epigenomic exploitation of host defenses Read More COVID-19 Wael Rabeh 8/20/24 COVID-19 Wael Rabeh 8/20/24 Key allosteric and active site residues of SARS-CoV-2 3CLpro are promising drug targets Read More COVID-19 Wael Rabeh 8/20/24 COVID-19 Wael Rabeh 8/20/24 pH profiles of 3-chymotrypsin-like protease (3CLpro) from SARS-CoV-2 elucidate its catalytic mechanism and a histidine residue critical for activity Read More COVID-19 Wael Rabeh 8/20/24 COVID-19 Wael Rabeh 8/20/24 The Discovery of Small Allosteric and Active Site Inhibitors of the SARS-CoV-2 Main Protease via Structure-Based Virtual Screening and Biological Evaluation Read More Newer Posts Older Posts Read about our research concentrations. Google Scholar ResearchGate
COVID-19 Wael Rabeh 8/20/24 COVID-19 Wael Rabeh 8/20/24 The Discovery of Novel Small Oxindole-Based Inhibitors Targeting the SARS-CoV-2 Main Protease (Mpro) Read More
COVID-19 Wael Rabeh 8/20/24 COVID-19 Wael Rabeh 8/20/24 SARS-CoV-2 variants, its recombinants and epigenomic exploitation of host defenses Read More
COVID-19 Wael Rabeh 8/20/24 COVID-19 Wael Rabeh 8/20/24 Key allosteric and active site residues of SARS-CoV-2 3CLpro are promising drug targets Read More
COVID-19 Wael Rabeh 8/20/24 COVID-19 Wael Rabeh 8/20/24 pH profiles of 3-chymotrypsin-like protease (3CLpro) from SARS-CoV-2 elucidate its catalytic mechanism and a histidine residue critical for activity Read More
COVID-19 Wael Rabeh 8/20/24 COVID-19 Wael Rabeh 8/20/24 The Discovery of Small Allosteric and Active Site Inhibitors of the SARS-CoV-2 Main Protease via Structure-Based Virtual Screening and Biological Evaluation Read More
